SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Boston Globe via Getty Images

61

Pfizer

PFE

In Ian Read’s final year as the company’s CEO, Pfizer managed to grow revenues by just 2% as it adjusted to greater competition to—and diminished sales of—Viagra and other drugs on which the company lost patent exclusivity in 2017. The pharmaceutical giant is now in the midst of a reorganization since announcing in the summer of 2018 that it would separate its business into three parts, one of which (its consumer health division) it plans to merge into a joint venture with GlaxoSmithKline. The moves are designed to position Pfizer for greater sales growth under new CEO Albert Bourla.

Looking for leads, investment insights, or competitive intelligence?

CEO

Albert Bourla

CEO Title

Chief Executive Officer & Director

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

New York, N.Y.

Years on Fortune 500 List

65

Employees

92,400

Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$53,6472.1%
Profits ($M)$11,153.0-47.7%
Assets ($M)$159,422
Total Stockholder Equity ($M)$63,407
Profit Ratios
Profit as % of Revenues20.8%
Profits as % of Assets7.0%
Profits as % of Stockholder Equity17.6%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)1.87
EPS % Change (from 2017)-46.9%
EPS % Change (5 year annual rate)-10.1%
EPS % Change (10 year annual rate)4.5%
Total Return
Total Return to Investors (2018)24.7%
Total Return to Investors (5 year, annualized)11.2%
Total Return to Investors (10 year, annualized)13.8%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Pfizer

Why A.I. Just Might Save Your Job

Walmart’s new robot “smart assistants” are good news for employees.

Read More →
Data Sheet–Drug Discovery Shifting From Treatment to Cure

This is your Data Sheet newsletter for Thursday, April 4, 2019.

Read More →
Viagra Sales Are Down. Here's Why Pfizer Maintains Its Market Lead Anyway

Pfizer also makes and markets a generic formula of its popular patented pill.

Read More →
Pfizer's Best-Selling Drug Is Actually a Vaccine—and Its Price Keeps Increasing

Prevnar 13 protects against infections including pneumonia, and is more popular than ever, thanks to the CDC.

Read More →